drugset / Trial / NCT00092326

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)

NCT00092326

Phase 3 Completed 269 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.

Timeline

Start
2002-06
Primary completion
2002-09
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule
Subject Oxycodone Other / unclassified
Subject rofecoxib Small molecule

Indications

No indication recorded.